SABBY MANAGEMENT, LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 53 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q1 2019$39,000
-91.9%
30,900
-84.5%
0.02%
-69.4%
Q3 2018$482,000
+37.7%
199,900
+233.2%
0.06%
+93.8%
Q4 2017$350,000
+11.1%
60,000
-60.0%
0.03%
+52.4%
Q3 2017$315,000
-46.2%
150,151
+20.0%
0.02%
-44.7%
Q2 2017$586,000
+25.5%
125,151
+109.6%
0.04%
+52.0%
Q1 2017$467,00059,7000.02%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q1 2018
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 440,627$2,093,0002.25%
NEA Management Company, LLC 5,556,778$26,395,0001.17%
Endurant Capital Management LP 472,012$2,242,0000.84%
DAFNA Capital Management LLC 267,100$1,269,0000.62%
RTW INVESTMENTS, LP 1,104,940$5,248,0000.50%
DOHENY ASSET MANAGEMENT /CA 69,625$331,0000.17%
BAILARD, INC. 520,100$2,470,0000.16%
Bain Capital Public Equity Management, LLC 399,947$1,900,0000.14%
Rock Springs Capital Management LP 675,000$3,206,0000.14%
Hillhouse Capital Management 865,923$4,113,0000.07%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders